Combined systemic immune-inflammatory index (SII) and prognostic nutritional index (PNI) predicts chemotherapy response and prognosis in locally advanced gastric cancer patients receiving neoadjuvant chemotherapy with PD-1 antibody sintilimab and XELOX: a prospective study

Ding, Ping’an; Guo, Honghai; Sun, Chenyu; Yang, Peigang; Hyun Kim, Na; Tian, Yuan; Liu, Yang; Liu, Pengpeng; Li, Yong; Zhao, Qun

doi:10.1186/s12876-022-02199-9

Public

Combined systemic immune-inflammatory index (SII) and prognostic nutritional index (PNI) predicts chemotherapy response and prognosis in locally advanced gastric cancer patients receiving neoadjuvant chemotherapy with PD-1 antibody sintilimab and XELOX: a prospective study

Published in BMC Gastroenterology • Mar 14, 2022

Authors:

Ping’an Ding

Honghai Guo

Chenyu Sun

Abstract

BACKGROUND: Previous studies have confirmed that systemic immune-inflammatory index (SII) and prognostic nutritional index (PNI) can predict the prognosis and chemotherapy efficacy of various malignant tumors. However, to the best of our knowledge, no study investigated the SII combined with PNI sco...

Subject

Medicine

Internal medicine

Capecitabine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!